ATE320449T1 - Fusionsprotein mit verbesserter in vivo erythropoietinwirkung - Google Patents

Fusionsprotein mit verbesserter in vivo erythropoietinwirkung

Info

Publication number
ATE320449T1
ATE320449T1 AT01270554T AT01270554T ATE320449T1 AT E320449 T1 ATE320449 T1 AT E320449T1 AT 01270554 T AT01270554 T AT 01270554T AT 01270554 T AT01270554 T AT 01270554T AT E320449 T1 ATE320449 T1 AT E320449T1
Authority
AT
Austria
Prior art keywords
fusion protein
vivo
erythropoiety
improved
effect
Prior art date
Application number
AT01270554T
Other languages
English (en)
Inventor
Dong-Eok Lee
Myung-Suk Oh
Ki-Wan Kim
Bo-Sup Chung
Byung-Jhip Ha
Ji-Sook Park
Original Assignee
Cheil Jedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020010072713A external-priority patent/KR101229995B1/ko
Application filed by Cheil Jedang Corp filed Critical Cheil Jedang Corp
Application granted granted Critical
Publication of ATE320449T1 publication Critical patent/ATE320449T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01270554T 2000-12-11 2001-12-10 Fusionsprotein mit verbesserter in vivo erythropoietinwirkung ATE320449T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20000075230 2000-12-11
KR1020010072713A KR101229995B1 (ko) 2000-12-11 2001-11-21 생체내 에리스로포이에틴 활성이 증진된 융합단백질

Publications (1)

Publication Number Publication Date
ATE320449T1 true ATE320449T1 (de) 2006-04-15

Family

ID=36178279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01270554T ATE320449T1 (de) 2000-12-11 2001-12-10 Fusionsprotein mit verbesserter in vivo erythropoietinwirkung

Country Status (6)

Country Link
EP (1) EP1342730B1 (de)
JP (1) JP3946638B2 (de)
AT (1) ATE320449T1 (de)
AU (1) AU2002222740A1 (de)
DE (1) DE60117919T2 (de)
WO (1) WO2002048194A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100467751B1 (ko) * 2001-12-03 2005-01-24 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
CA2485365A1 (en) * 2002-05-13 2003-11-20 Modigenetech Ltd. Ctp-extended erythropoietin
US7625564B2 (en) 2006-01-27 2009-12-01 Novagen Holding Corporation Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US10221228B2 (en) 2006-02-03 2019-03-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8476234B2 (en) 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US7553940B2 (en) * 2006-02-03 2009-06-30 Modigene Inc Long-acting EPO polypeptides and derivatives thereof and methods thereof
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US8450269B2 (en) 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US8759292B2 (en) 2006-02-03 2014-06-24 Prolor Biotech, Llc Long-acting coagulation factors and methods of producing same
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
WO2009012600A1 (en) 2007-07-26 2009-01-29 Novagen Holding Corporation Fusion proteins
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
US12203113B2 (en) 2009-07-09 2025-01-21 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
BR112014025951A2 (pt) 2012-04-19 2017-07-11 Opko Biologics Ltd variantes de oxintomodulina de longa ação e métodos de produção do mesmo
BR112015011583B1 (pt) 2012-11-20 2023-03-14 Opko Biologics Ltd Métodos para aumentar o tamanho ou volume hidrodinâmico de hormônio de crescimento humano, método para aumentar o peso molecular aparente de um polipeptídeo e método para aumentar a meia-vida de um polipeptídeo
CN103864913A (zh) 2012-12-18 2014-06-18 联亚生技开发股份有限公司 重组蛋白
EP2968391A1 (de) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Langlebige polynukleotidmoleküle
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
SG11201704706RA (en) 2014-12-10 2017-07-28 Opko Biologics Ltd Methods of producing long acting ctp-modified growth hormone polypeptides
HUE055449T2 (hu) 2015-06-19 2021-11-29 Opko Biologics Ltd Hosszú hatástartamú koagulációs faktorok és eljárások ezek elõállítására
EP3481855B1 (de) 2016-07-11 2023-09-06 OPKO Biologics Ltd. Langwirkender gerinnungsfaktor vii und verfahren zur herstellung davon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053864C (en) * 1989-02-21 2001-11-20 Irving Boime Modified forms of reproductive hormones
US5792460A (en) * 1989-02-21 1998-08-11 Washington University Modified glycoprotein hormones having a CTP at the amino terminus
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
JPH07501450A (ja) * 1991-11-29 1995-02-16 モンサント　カンパニー 環状ジグアニレート代謝酵素
ATE187740T1 (de) * 1993-04-20 2000-01-15 Univ Washington Modifizierte proteine und peptide enthaltende pharmazeutische mittel
IL110669A (en) * 1993-08-17 2008-11-26 Kirin Amgen Inc Erythropoietin analogs
JO2291B1 (en) * 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythropoietin derivatives

Also Published As

Publication number Publication date
EP1342730A1 (de) 2003-09-10
WO2002048194A1 (en) 2002-06-20
JP3946638B2 (ja) 2007-07-18
DE60117919D1 (de) 2006-05-11
EP1342730A4 (de) 2004-06-23
DE60117919T2 (de) 2006-12-14
JP2004515246A (ja) 2004-05-27
AU2002222740A1 (en) 2002-06-24
EP1342730B1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
DE60117919D1 (de) Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
BR0203386A (pt) Proteìna de fusão, ácido nucleico codificador e método para a preparação de uma proteìna de fusão possuindo uma melhorada atividade epo in-vivo
RU2002123286A (ru) Слитый белок с увеличенной эритропоэтиновой активностью, нуклеиновая кислота, кодирующая слитый белок, и способ получения слитого белка
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
ECSP064643A (es) Proteinas de fusion de glp-1
AU2003228962A1 (en) Ferritin fusion proteins for use in vaccines and other applications
CA2237296A1 (en) Process for the preparation of peptides by way of streptavidin fusion proteins
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
RU2002123438A (ru) Слитый белок, обладающий in vivo повышенной активностью эритропоэтина
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
AU2003252111A8 (en) Fluorescent proteins, nucleic acids encoding them and methods for making and using them
DE69931284D1 (de) Menschliches Neurotrimin-Homolog
WO2000015659A3 (en) Stomach polypeptide zsig28
CO5241364A1 (es) Vacunas la zoster
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP1409683A4 (de) Helicobacter-proteine, -nukleinsäuren und deren verwendung
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
AU654155B2 (en) A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene
DE69932644D1 (de) Menschliches Protein mit in vitro antiproliferativer Aktivität.
AU2002232452A1 (en) Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
WO2001057086A3 (en) Novel human g protein coupled receptor proteins and polynucleotides encoding the same
WO2002016435A3 (en) Human 7tm proteins and polynucleotides encoding the same
WO2001072842A3 (en) Human 7-transmembrane proteins and polynucleotides encoding the same
WO1999036440A3 (en) Expression of fusion proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties